121 |
Role of vascular plasticity in muscle remodeling in the child / Rôle de la plasticité vasculaire dans le remodelage musculaire chez l’enfantGitiaux, Cyril 27 March 2015 (has links)
Le muscle strié squelettique est un tissu richement vascularisé. Au delà de l'apport en oxygène et en nutriments, de nouvelles fonctions des vaisseaux ont été récemment identifiées, par le biais des interactions établies entre les cellules du vaisseau (cellules endothéliales) et les cellules du muscle, en particulier les cellules souches musculaires (cellules satellites). Celles-ci interagissent étroitement avec les cellules endothéliales pour leur expansion et leur différenciation, puis avec les cellules péri-endothéliales pour leur auto-renouvellement et leur retour à la quiescence. Les vaisseaux participent ainsi au contrôle de l’homéostasie du muscle squelettique. Grâce à ces interactions, les cellules vasculaires jouent donc un rôle central dans le remodelage tissulaire après un phénomène destructif, survenant par exemple au cours d’un trauma ou d’une myopathie. Pour étudier, les mécanismes de la plasticité vasculaire au cours du remodelage tissulaire, deux situations paradigmatiques de muscle en régénération chez l’enfant : la dermatomyosite juvénile (DMJ) et la dystrophie musculaire de Duchenne (DMD) ont été étudiées. Il existe, dans ces deux pathologies une souffrance musculaire associée à des cycles de nécrose/régénération. Elles se différencient par leur plasticité vasculaire et par leur évolution. En effet, la DMJ, la myopathie inflammatoire la plus fréquente de l’enfant est caractérisée par une vasculopathie avec perte en capillaires. L’évolution peut être favorable avec restitution ad integrum du muscle. La DMD est une myopathie génétique conduisant à une dégradation progressive de la force musculaire associée à une néovascularisation compensatrice. Le volet clinique/histologique incluant une analyse multiparamétrique des critères évolutifs cliniques et de réponse thérapeutique couplée à une réévaluation des données histologiques de la DMJ (analyse morphométrique des muscles DMJ) a permis de montrer qu’il existait des sous groupes phénotypiques homogènes de sévérité différente dans la DMJ. Le degré de sévérité clinique est relié à la gravité de la vasculopathie musculaire Par ailleurs, des marqueurs cliniques et histologiques simples permettant de repérer au diagnostic les patients nécessitant une escalade thérapeutique rapide (CMAS>34, atteinte gastrointestinale, fibrose endomysiale musculaire au diagnostic) ont été identifiés. Le volet cellulaire a permis l’identification in vitro des interactions cellulaires spécifiques et différentielles des myoblastes issues de patients DMD et DMJ sur les cellules endothéliales normales par l’analyse de leur rôle sur la prolifération, migration et différenciation des cellules vasculaires. Dans la DMD, les myoblastes entrainent une réponse angiogénique importante mais non efficace (néovascularisation anarchique). Dans la DMJ, les myoblastes participent efficacement à la reconstruction vasculaire notamment via la sécrétion de facteurs proangiogéniques. Ces résultats ont été renforcés par analyse transcriptomique effectuée à partir de cellules endothéliales et satellites isolées de muscles de patients confirmant le rôle central de la vasculopathie associée à un contexte inflammatoire spécifique lié à l’interféron dans la physiopathologie de la DMJ et montrant dans la DMD une dérégulation de l’homéostasie normale des interactions vaisseau-muscle avec mise en jeu d’un remodelage tissulaire non efficace. Ces données permettent d'identifier de nouvelles fonctions des cellules vasculaires dans le remodelage du muscle strié squelettique au cours des pathologies musculaires de l'enfant, et devraient ouvrir la voie à de nouvelles approches thérapeutiques. / Skeletal muscle is highly vascularised. Beyond oxygen and nutriment supply, new functions for vessels have been recently identified, through the interactions that vessel cells (endothelial cells) establish with muscle cells, particularly with muscle stem cells (satellite cells). These latter closely interact with endothelial cells for their expansion and their differentiation, then with periendothelial cells for their self-renewal and return to quiescence. During skeletal muscle regeneration endothelial cells reciprocally interact with myogenic cells by direct contact or by releasing soluble factors to promote both myogenesis and angiogenesis processes. Skeletal muscle regeneration typically occurs as a result of a trauma or disease, such as congenital or myopathies. To better understand the role of vessel plasticity in tissue remodeling, we took advantage of two muscular disorders that could be considered as paradigmatic situations of regenerating skeletal muscle in the child: Juvenile Dermatomyositis (JDM), the most frequent inflammatory myopathy and Duchenne Muscular Dystrophy (DMD), the most common type of muscular dystrophy. Although these two muscular disorders share, at the tissue level, similar mechanisms of necrosis-inflammation, they differ regarding the vessel domain. In JDM patients, microvascular changes consist in a destruction of endothelial cells assessed by focal capillary loss. This capillary bed destruction is transient. The tissue remodeling is efficient and muscle may progressively recover its function. By contrast, in DMD, despite an increase of vessels density in an attempt to improve the muscle perfusion, the muscle function progressively alters with age. We identified clinical and pathological markers of severity and predictive factors for poor clinical outcome in JDM by computing a comprehensive initial and follow-up clinical data set with deltoid muscle biopsy alterations controlled by age-based analysis of the deltoid muscle capillarization. We demonstrated that JDM can be divided into two distinctive clinical subgroups. The severe clinical presentation and outcome are linked to vasculopathy. Furthermore, a set of simple predictors (CMAS<34, gastrointestinal involvement, muscle endomysial fibrosis at disease onset) allow early recognition of patients needing rapid therapeutic escalation with more potent drugs. We studied in vitro the specific cell interactions between myogenic cells issued from JDM and DMD patients and normal endothelial cells to explore whether myogenic cells participate to the vessel remodeling observed in the two pathologies. We demonstrated that MPCs possessed angiogenic properties depending on the pathological environment. In DMD, MPCs promoted the development of establishment of an anarchic, although strong, EC stimulation, leading to the formation of weakly functional vessels. In JDM, MPCs enhanced the vessel reconstruction via the secretion of proangiogenic factors. This functional analysis was supported by the transcriptomic analysis consistent with a central vasculopathy in JDM including a strong and specific response to an inflammatory environment. On the contrary, DMD cells presented an unbalanced homeostasis with deregulation of several processes including muscle and vessel development with attempts to recover neuromuscular system by MPCs. To summarize, our data should allow the definition of new functions of vessel cells in skeletal muscle remodelling during muscle pathologies of the child that will open the way to explore new therapeutic options and to gain further insights in the pathogenesis of these diseases.
|
122 |
Role of vascular plasticity in muscle remodeling in the child / Rôle de la plasticité vasculaire dans le remodelage musculaire chez l’enfantGitiaux, Cyril 27 March 2015 (has links)
Le muscle strié squelettique est un tissu richement vascularisé. Au delà de l'apport en oxygène et en nutriments, de nouvelles fonctions des vaisseaux ont été récemment identifiées, par le biais des interactions établies entre les cellules du vaisseau (cellules endothéliales) et les cellules du muscle, en particulier les cellules souches musculaires (cellules satellites). Celles-ci interagissent étroitement avec les cellules endothéliales pour leur expansion et leur différenciation, puis avec les cellules péri-endothéliales pour leur auto-renouvellement et leur retour à la quiescence. Les vaisseaux participent ainsi au contrôle de l’homéostasie du muscle squelettique. Grâce à ces interactions, les cellules vasculaires jouent donc un rôle central dans le remodelage tissulaire après un phénomène destructif, survenant par exemple au cours d’un trauma ou d’une myopathie. Pour étudier, les mécanismes de la plasticité vasculaire au cours du remodelage tissulaire, deux situations paradigmatiques de muscle en régénération chez l’enfant : la dermatomyosite juvénile (DMJ) et la dystrophie musculaire de Duchenne (DMD) ont été étudiées. Il existe, dans ces deux pathologies une souffrance musculaire associée à des cycles de nécrose/régénération. Elles se différencient par leur plasticité vasculaire et par leur évolution. En effet, la DMJ, la myopathie inflammatoire la plus fréquente de l’enfant est caractérisée par une vasculopathie avec perte en capillaires. L’évolution peut être favorable avec restitution ad integrum du muscle. La DMD est une myopathie génétique conduisant à une dégradation progressive de la force musculaire associée à une néovascularisation compensatrice. Le volet clinique/histologique incluant une analyse multiparamétrique des critères évolutifs cliniques et de réponse thérapeutique couplée à une réévaluation des données histologiques de la DMJ (analyse morphométrique des muscles DMJ) a permis de montrer qu’il existait des sous groupes phénotypiques homogènes de sévérité différente dans la DMJ. Le degré de sévérité clinique est relié à la gravité de la vasculopathie musculaire Par ailleurs, des marqueurs cliniques et histologiques simples permettant de repérer au diagnostic les patients nécessitant une escalade thérapeutique rapide (CMAS>34, atteinte gastrointestinale, fibrose endomysiale musculaire au diagnostic) ont été identifiés. Le volet cellulaire a permis l’identification in vitro des interactions cellulaires spécifiques et différentielles des myoblastes issues de patients DMD et DMJ sur les cellules endothéliales normales par l’analyse de leur rôle sur la prolifération, migration et différenciation des cellules vasculaires. Dans la DMD, les myoblastes entrainent une réponse angiogénique importante mais non efficace (néovascularisation anarchique). Dans la DMJ, les myoblastes participent efficacement à la reconstruction vasculaire notamment via la sécrétion de facteurs proangiogéniques. Ces résultats ont été renforcés par analyse transcriptomique effectuée à partir de cellules endothéliales et satellites isolées de muscles de patients confirmant le rôle central de la vasculopathie associée à un contexte inflammatoire spécifique lié à l’interféron dans la physiopathologie de la DMJ et montrant dans la DMD une dérégulation de l’homéostasie normale des interactions vaisseau-muscle avec mise en jeu d’un remodelage tissulaire non efficace. Ces données permettent d'identifier de nouvelles fonctions des cellules vasculaires dans le remodelage du muscle strié squelettique au cours des pathologies musculaires de l'enfant, et devraient ouvrir la voie à de nouvelles approches thérapeutiques. / Skeletal muscle is highly vascularised. Beyond oxygen and nutriment supply, new functions for vessels have been recently identified, through the interactions that vessel cells (endothelial cells) establish with muscle cells, particularly with muscle stem cells (satellite cells). These latter closely interact with endothelial cells for their expansion and their differentiation, then with periendothelial cells for their self-renewal and return to quiescence. During skeletal muscle regeneration endothelial cells reciprocally interact with myogenic cells by direct contact or by releasing soluble factors to promote both myogenesis and angiogenesis processes. Skeletal muscle regeneration typically occurs as a result of a trauma or disease, such as congenital or myopathies. To better understand the role of vessel plasticity in tissue remodeling, we took advantage of two muscular disorders that could be considered as paradigmatic situations of regenerating skeletal muscle in the child: Juvenile Dermatomyositis (JDM), the most frequent inflammatory myopathy and Duchenne Muscular Dystrophy (DMD), the most common type of muscular dystrophy. Although these two muscular disorders share, at the tissue level, similar mechanisms of necrosis-inflammation, they differ regarding the vessel domain. In JDM patients, microvascular changes consist in a destruction of endothelial cells assessed by focal capillary loss. This capillary bed destruction is transient. The tissue remodeling is efficient and muscle may progressively recover its function. By contrast, in DMD, despite an increase of vessels density in an attempt to improve the muscle perfusion, the muscle function progressively alters with age. We identified clinical and pathological markers of severity and predictive factors for poor clinical outcome in JDM by computing a comprehensive initial and follow-up clinical data set with deltoid muscle biopsy alterations controlled by age-based analysis of the deltoid muscle capillarization. We demonstrated that JDM can be divided into two distinctive clinical subgroups. The severe clinical presentation and outcome are linked to vasculopathy. Furthermore, a set of simple predictors (CMAS<34, gastrointestinal involvement, muscle endomysial fibrosis at disease onset) allow early recognition of patients needing rapid therapeutic escalation with more potent drugs. We studied in vitro the specific cell interactions between myogenic cells issued from JDM and DMD patients and normal endothelial cells to explore whether myogenic cells participate to the vessel remodeling observed in the two pathologies. We demonstrated that MPCs possessed angiogenic properties depending on the pathological environment. In DMD, MPCs promoted the development of establishment of an anarchic, although strong, EC stimulation, leading to the formation of weakly functional vessels. In JDM, MPCs enhanced the vessel reconstruction via the secretion of proangiogenic factors. This functional analysis was supported by the transcriptomic analysis consistent with a central vasculopathy in JDM including a strong and specific response to an inflammatory environment. On the contrary, DMD cells presented an unbalanced homeostasis with deregulation of several processes including muscle and vessel development with attempts to recover neuromuscular system by MPCs. To summarize, our data should allow the definition of new functions of vessel cells in skeletal muscle remodelling during muscle pathologies of the child that will open the way to explore new therapeutic options and to gain further insights in the pathogenesis of these diseases.
|
123 |
Vulnérabilité cardiaque au stress au cours du remodelage ventriculaire pathologique : rôle de la mitochondrie et du pore de perméabilité transitionnelle (PTP)Ascah, Alexis 12 1900 (has links)
L’objectif central de cette thèse de Doctorat était d’investiguer les dysfonctions mitochondriales qui surviennent précocement au cours de la phase compensée du remodelage ventriculaire pathologique et qui pourraient jouer un rôle causal dans la progression vers l’insuffisance cardiaque.
Nos travaux antérieurs, réalisés à l’aide d’un modèle de surcharge volumique chronique induite par une fistule aorto-cavale (ACF) chez le Rat WKHA, ont montré qu’au cours du remodelage ventriculaire, les mitochondries développaient une vulnérabilité à l’ouverture du pore de perméabilité transitionnelle (PTP : un élément clé de la signalisation de la mort cellulaire) [1]. Ceci était observable au stade compensé du remodelage en absence des dysfonctions mitochondriales majeures typiquement observées dans le cœur insuffisant. Ces résultats nous ont amenés à suggérer que la vulnérabilité à l’ouverture du PTP pourrait constituer un mécanisme précoce favorisant la progression de la cardiopathie. Dans l’étude 1 de cette thèse, nous avons tenté de tester cette hypothèse en induisant une ACF chez deux souches de rats affichant de très nettes différences au niveau de la propension à développer l’insuffisance cardiaque : les souches WKHA et Sprague Dawley (SD). Nos études in vitro sur organelles isolées et in situ sur l’organe entier ont permis de confirmer que, dans le cœur ACF, les mitochondries développent une vulnérabilité à l’ouverture du PTP et à l’activation de la voie mitochondriale de la mort cellulaire lorsqu’exposées à des stress pertinents à la pathologie (surcharge calcique, ischémie-reperfusion [I-R]). Cependant, bien que comparativement aux animaux WKHA, les animaux SD démontraient un remodelage ventriculaire plus rapide et prononcé et une progression précoce vers l’insuffisance cardiaque, aucune différence n’était observable entre les deux groupes au niveau des dysfonctions mitochondriales, suggérant quelles ne sont pas à l’origine de la progression plus rapide de la pathologie chez la souche SD, à tout le moins en réponse à la surcharge volumique.
Nous avons par la suite déterminé, à l’aide des mêmes approches expérimentales, si cette vulnérabilité mitochondriale était observable dans une cardiopathie d’étiologie différente, plus spécifiquement celle qui est associée à la dystrophie musculaire de Duchenne (DMD), une maladie génétique causée par une mutation de la protéine dystrophine. Nos études menées (études 2-4) sur de jeunes souris mdx (le modèle murin de la DMD) exemptes de tout signe clinique de cardiopathie n’ont révélé aucune différence au niveau des fonctions mitochondriales de base. Cependant, tout comme dans le modèle d’ACF, les mitochondries dans le cœur de souris mdx étaient significativement plus vulnérables à l’ouverture du PTP lorsque soumises à une I-R (étude 2). Par ailleurs, nous avons démontré que l’administration aiguë de sildénafil aux souris mdx induisait une abolition de l’ouverture du PTP et de ses conséquences signalétiques, une diminution marquée du dommage tissulaire et une meilleure récupération fonctionnelle à la suite de l’I-R (étude 3). Nous avons ensuite testé chez la souris mdx l’administration aiguë de SS31, un peptide anti-oxydant ciblé aux mitochondries, cependant aucun effet protecteur n’a été observé, suggérant que le tamponnement des radicaux libres est d’une utilité limitée si les perturbations de l’homéostasie calcique typiques à cette pathologie ne sont pas traitées simultanément (étude 4).
Globalement, les travaux effectués au cours de cette thèse démontrent que la vulnérabilité à l’ouverture du PTP constitue une dysfonction précoce et commune qui survient au cours de remodelages ventriculaires pathologiques d’étiologies différentes. Par ailleurs, ces travaux suggèrent des stratégies d’intervention pharmacologiques ciblant ce processus, dont l’efficacité pour la prévention de l’insuffisance cardiaque demande à être établie. / The central objective of this doctoral thesis was to investigate the mitochondrial dysfunction that occurs early during the compensated phase of pathological ventricular remodeling and which may play a causal role in the progression to heart failure.
Our previous work using a model of chronic volume overload induced by aorto-caval fistula (ACF) in rats WKHA showed that during the ventricular remodeling, mitochondria developed a vulnerability to permeability transition pore opening (PTP: a key component of cell death signaling) [1]. This was observed at the stage of compensated remodeling in the absence of major mitochondrial dysfunction typically observed in the failing heart. These results led us to suggest that the vulnerability to PTP opening could be a mechanism facilitating the progression of the cardiomyopathy. In our first study of this thesis we have attempted to test this hypothesis by inducing ACF in two strains of rats displaying sharp differences in the propensity to develop heart failure: WKHA strains and Sprague Dawley (SD). Our studies in vitro on isolated organelles and in situ on the whole organ have confirmed that, in the ACF heart, mitochondria develop a vulnerability to PTP opening and activation of mitochondrial cell death when exposed to stresses relevant to the pathology (calcium overload, ischemia-reperfusion [I-R]). However, SD animals compared to WKHA showed a more rapid and pronounced ventricular remodeling and early progression to heart failure, no difference was found between the two groups in terms of mitochondrial dysfunction, suggesting that this is not behind the more rapid progression of the disease in the SD strain, at least in response to volume overload.
We subsequently determined, using the same experimental approaches, if this vulnerability was observed in mitochondria of heart disease from other etiology more specifically that associated with Duchenne muscular dystrophy (DMD), a genetic disease caused by a mutation of the protein dystrophin. Our studies (studies 2-4) on young mdx mice (the mouse model of DMD) free of clinical signs of heart disease showed no difference in basal mitochondrial functions. However, as in the model of ACF, the mitochondria of mdx mice heart were significantly more vulnerable to PTP opening when subjected to I-R (study 2). Furthermore, we demonstrated that acute administration of sildenafil to mdx mice abolished the PTP opening and its signaling consequences, markedly reduced of tissue damage and improved functional recovery following I-R (Study 3). We then tested in mdx mice acute administration of SS31, an antioxidant peptide that targets and accumulates in mitochondria. However, no protective effect was observed, suggesting that the buffering of free radicals have a limited utility if the typical perturbations of the calcium homeostasis in this disease are not treated simultaneously (Study 4).
Overall, the work done during this thesis show that the vulnerability to PTP opening is a common and early dysfunction that occurs during pathological ventricular remodeling of different etiologies. Moreover, these studies suggest pharmacological intervention strategies targeting this process, whose effectiveness in preventing heart failure needs to be established.
|
124 |
Relação entre força muscular e função motora em pacientes com distrofia muscular de Duchenne: acompanhamento de quatro anos / Relationship between muscle strength and motor function in Duchenne muscular dystrophy: follow-up four yearsNunes, Milene Franco de Souza 08 April 2016 (has links)
OBJETIVO: Investigar a relação entre força muscular e função motora, em pacientes com DMD, em um período de 4 anos consecutivos, a partir de avaliações semestrais. MÉTODO: A força muscular foi medida por meio de testes manuais e o cálculo por grupo muscular seguiu o proposto pelo Medical Research Council (MRC) e a função motora pelo método de Medida da Função Motora (MFM), em 43 pacientes (8-30 anos). Foi realizada uma análise descritiva e o teste de correlação de Spearman. Foram investigadas as relações entre pontuações totais e parciais da MRC e da MFM. RESULTADOS: O estudo evidenciou correlações classificadas de moderada a forte relação entre a força muscular e função motora, principalmente com o escore total da MFM e a dimensão D2 (musculatura axial e função motora proximal). Foi encontrada relação negativa moderada entre idade e essas variáveis. CONCLUSÃO: A perda progressiva da função motora tem relação direta e proporcional com a diminuição da força muscular. Quanto maior a idade do paciente, pior sua função motora e força muscular, fornecendo com essa informação, indicadores adicionais da progressão da doença / OBJECTIVE: This study investigated this relationship and examined whether muscle strength and/or motor function would be related to age in DMD. METHODS: Muscle strength was measured by the Medical Research Council scale (MRC) and motor function by the Motor Function Measure (MFM) in 43 patients (8-30 yrs). Spearman tests, descriptive analysis, investigated the relationships between total/ partial scores of MRC and MFM. RESULTS: Total MRC and MFM scores were strongly related to each other and moderately related to age. Many strong relationships between partial MRC and MFM scores were found, mostly between partial MRC scores and MFM dimension 2 (axial and proximal motor function). CONCLUSION: It is possible to predict that the progressive loss of motor function has direct relationship to decreased muscle strength. That the older the patient, the worse their motor function and muscle strength, providing with this information, additional indicators of disease progression
|
125 |
Evolução do tempo e dos movimentos compensatórios durante a marcha e o subir e descer degraus em crianças com distrofia muscular de Duchenne / Progression of timed performance and compensatory movements during walking and climbing up and down steps in children with Duchenne muscular dystrophyMartini, Joyce 22 June 2015 (has links)
Contextualização: O tempo e, mais recentemente, a análise dos movimentos compensatórios, têm sido utilizados na avaliação funcional de crianças com distrofia muscular de Duchenne (DMD). Embora estejam relacionadas, essas duas variáveis podem progredir distintamente em crianças com DMD, no intervalo de um ano. Objetivo: Descrever e comparar a evolução do tempo e dos movimentos compensatórios durante atividades de locomoção em crianças com DMD no período de um ano. Método: Foram avaliados filmes de 32 meninos (média de idade 10 anos) durante a marcha em local plano, por 10 m, o subir e o descer quatro degraus. O tempo foi cronometrado e utilizou-se a escala de avaliação funcional para DMD (Functional Evaluation Scale for Duchenne Muscular Dystrophy, FES-DMD) para pontuar os movimentos compensatórios. Aplicou-se a análise multivariável de variância (MANOVA), com (alfa < 0.05) para comparar as variáveis em três momentos: avaliação inicial (AV0), após 6 meses (AV6) e após 12 meses (AV12). Resultados: Os movimentos compensatórios mais comuns observados durante a marcha foram flexão plantar de tornozelos, aumento da base de apoio, anteriorização de cabeça e tronco e aumento da dissociação de cinturas. Na atividade de subir degraus foram flexão plantar de tornozelos, aumento da base de apoio, hiperlordose lombar e aumento da inclinação lateral do tronco. Ao descer degraus, esses movimentos também foram observados, acrescidos de rotação de tronco, flexão do joelho de apoio, flexão plantar do tornozelo de balanço e descida parando em cada degrau. A MANOVA mostrou que as variáveis aumentaram significativamente no período de um ano (p < 0,05 para todas as comparações) durante a marcha, o subir e o descer degraus. Interações entre o tempo e a pontuação dos movimentos compensatórios evidenciaram progressões distintas durante o subir e descer degraus (p < 0,05 para ambos). Durante a marcha, o tempo aumentou 47% e a pontuação dos movimentos compensatórios aumentou 55%. Ao subir degraus, o tempo aumentou 144% e a pontuação dos movimentos compensatórios aumentou 44%. Durante o descer degraus, o tempo aumentou 186% e a pontuação dos movimentos compensatórios aumentou 58%. Conclusão: Na marcha, as crianças com DMD mostraram aumento discretamente maior dos movimentos compensatórios, quando comparado ao aumento do tempo. Durante o subir e descer degraus, o aumento do tempo foi mais expressivo do que o aumento dos movimentos compensatórios. Acompanhar a evolução do tempo e dos movimentos compensatórios em crianças com DMD permitiu uma avaliação mais precisa e o acompanhamento da progressão das tarefas de locomoção / Introduction: Timed performance and, more recently, compensatory movements, have been used to assess children with Duchenne muscular dystrophy (DMD). Although being strongly related, these variables may progress distinctly within one year. Objective: To describe and compare the progression of timed performance and compensatory movements on locomotion tasks in children with DMD, followed for one year. Method: Films of 32 boys (mean age 10 yrs) performing 10-m walking, climbing up and down four steps were analyzed. Time was digitally measured and compensatory movements were quantified with the Functional Evaluation Scale for DMD (FES-DMD). Multivariate analyses of variance (MANOVAs) (alfa < 0.05) compared the variables on three assessments: initial (A0), after 6 months (A6) and after 12 months (A12). Results: The most common compensatory movements on walking were ankles plantar flexion, increased base of support, head and trunk anteriorization and increased upper and lower body dissociation. On climbing up steps, ankles plantar flexion, increased base of support, lumbar hyperlordosis and excessive trunk lateral inclination. On climbing down steps, these movements were also observed, associated to trunk rotation, stance knee flexion, equinus swing foot and pauses after steps. MANOVAs showed that both variables increased significantly within one year (p < 0.05 for all comparisons) on walking, climbing up and climbing down steps. Interactions between timed performance and compensatory movements evidenced distinct progressions of timed performance and compensatory movements on climbing up and down steps (p < 0.05 for both). On walking, timed performance increased 47% and compensatory movements increased 55%. On climbing up steps, timed performance increased 144% and compensatory movements increased 44%. On climbing down steps, timed performance increased 186% and compensatory movements increased 58%. Conclusion: On walking, children with DMD showed a discrete higher increase of compensatory movements, compared to the increase of timed performance. However, when climbing up and down steps, the timed performance increased much more than the compensatory movements. Evaluating the progression of timed performance and compensatory movements in children with DMD allowed more precise assessment and follow up of locomotion tasks evolution
|
126 |
Modelagem neuronal de pacientes com distrofia muscular de Duchenne utilizando células pluripotentes induzidas / Neuronal modelling with Duchenne muscular dystrophy patients using pluripotent stem cellsFernandes, Isabella Rodrigues 22 April 2015 (has links)
A Distrofia Muscular de Duchenne (DMD) é uma patologia neuromuscular causada pela mutação ou deleção do gene da distrofina, localizado no cromossomo X, levando a degeneração muscular ao longo da vida do paciente. A doença também tem sido associada a déficit cognitivo e falta de habilidade comportamental. Pesquisas com células neurais de pacientes com DMD poderiam ajudar a elucidar os sintomas neurológicos associados. Neste trabalho, através de células-tronco pluripotentes induzidas (iPSC) derivadas da polpa de dente decíduo esfoliado (SHED) de pacientes com DMD modelamos a DMD produzindo células neurais vivas in vitro. A expressão da distrofina foi verificada durante e após a diferenciação neuronal e nos ensaios de imunofluorescência, mostrando que essa proteína está presente em células do SNC. Na análise gênica através do qPCR, a Dp71 e a Dp140, isoformas da distrofina, apresentavam uma expressão menor do que os controles. Além disso, as análises das sinapses baseada na colocalização de marcadores pré e pós-sinápticos (Sinapsina1 e Homer 1) revelaram que os neurônios dos pacientes com DMD tinham menor quantidade de sinapses que os controles, reforçando o papel da distrofina no SNC. Logo, a expressão de genes relacionados a plasticidade sináptica revelou 10 genes alterados nos neurônios dos pacientes DMD, sugerindo que a mutação no gene da distrofina possivelmente altera a plasticidade sináptica e pode estar envolvida na habilidade cognitiva destes pacientes. Desta forma, com base nos nossos achados, a modelagem neuronal de DMD é factível e pode auxiliar a elucidar os mecanismos da fisiopatologia da doença / The Duchenne muscular dystrophy (DMD) is a neuromuscular disorder caused by a mutation or deletion of the dystrophin gene located on the X chromosome, leading to muscle degeneration throughout the patient\'s life. The disease has also been associated with cognitive impairment and lack of behavioral skill. Research on neural cells from patients with DMD could help to elucidate the neurological symptoms associated. In this work, through induced pluripotent stem cells (iPSC) derived from dental pulp exfoliated (SHED) of patients with DMD model the DMD producing living neural cells in vitro. The dystrophin expression was observed during and after neuronal differentiation and immunofluorescence assays, showing that this protein is present in CNS cells. In gene analysis by qPCR, the Dp71 and Dp140, isoforms of dystrophin, had a lower expression than controls. Furthermore, based on analysis of synapses colocalization pre and postsynaptic markers (Synapsin1 and Homer 1) showed that neurons of DMD patients had lower number of synapses controls, supporting a role for dystrophin in the CNS. Finally, the expression of synaptic plasticity related genes wasfound in 10 genes altered in neurons of DMD patients, suggesting that the mutation of the dystrophin gene possibly alters synaptic plasticity and may be involved in cognitive ability of these patients. Finally, based on our findings, neuronal modeling DMD is feasible and may help elucidate the mechanisms of pathophysiology of the disease
|
127 |
Common and distinct immunological aspects in acquired inflammatory myopathies and inherited muscular dystrophyPreuße, Corinna 08 December 2014 (has links)
Die heterogene Gruppe der Myopathien kann sowohl die Funktion des Muskels beeinflussen, als auch andere Organsysteme. Erworbenen Muskelerkrankungen sind theoretisch behandelbar, jedoch stehen zumeist nur sehr unspezifische Behandlungsoptionen zur Verfügung, während für vererbte Formen bisher keine kausalen Therapiemöglichkeiten bekannt sind. In dieser Arbeit wurden drei verschiedene Muskelerkrankungen untersucht. Gemeinsam ist ihnen ein jeweils charakteristischer Einstrom von Entzündungszellen, wobei die Zusammensetzung des Zellinfiltrates (z.B. Lymphozyten oder Makrophagen) bei den verschieden Erkrankungen unterschiedlich war. Weiterhin unterscheidet sich das zugrunde liegende Zytokinmilieu für die einzelnen untersuchten Entitäten. Daher war es Ziel der Arbeit, die genauen Interaktionen zwischen den Immunzellen zu untersuchen, sowie die charakteristischen Phänomene der Erkrankungen (Hypoxie, Entzündung und Fibrose). Nekrotisierende Myopathien können sowohl durch eine immun-vermittelte Genese, als auch durch Kontakt mit toxischen Substanzen ausgelöst werden und beide Subgruppen können klar durch morphologische Kriterien, als auch durch spezielle Immunaspekte unterschieden werden. Makrophagen waren hier die vorherrschende Zellpopulation und im gesamten Muskel verteilt. Patienten mit Dermatomyositis dagegen zeigten ein typisches perifaszikuläres Atrophiemuster und hypoxische Effekte, wobei beide Phänomene deutlich ausgeprägter bei juvenilen, als bei adulten Patienten vorkamen. Erbliche Myopathien (z.B. Muskeldystrophie Duchenne) können ebenfalls entzündliche Infiltrate aufweisen und die Entwicklung von Fibrose in der Skelettmuskulatur ist dabei ein Hauptkriterium der Muskelfaserdegeneration. Ein neu entwickelter computer-basierter Algorithmus wurde genutzt, um diese Entwicklung zu quantifizieren. Die Menge an Bindegewebe steigt mit dem Alter der Patienten, während bei älteren Patienten außerdem ein fettgewebiger Umbau ein wichtiger Aspekt der Pathologie war. / The heterogeneous group of myopathies can affect the skeletal muscle or other organ systems and comprise a huge number of different entities. Acquired myopathies are potentially treatable, but there are often only unspecific treatment options, while there is no causative cure for inherited forms of myopathies. In this work, three different entities were analyzed, which all share common aspects of the immune response, but also feature distinct immunological aspects as well. They have an inflammatory part in common, which is mainly regulated by influx of immune cells. However, the composition of these cellular infiltrates (e.g. lymphocytes or macrophages) was varying between the diseases. In addition, the respective cytokine milieu was highly specific in the examined entities. Thus, the aim of the study was to precisely examine interactions between immune cells, and analyze characteristic pathological phenomena (hypoxia, inflammation and fibrosis). Necrotizing myopathies have an immune-mediated background or showed a toxic aetiology and both sub-groups can be distinguished by their morphological characteristics and certain immune aspects. Here macrophages are the predominant cell population and are spread throughout the muscle. Analyses of patients suffering from dermatomyositis showed a typical perifascicular pattern of atrophy, as well as effects of hypoxia and the described features are in general more pronounced in juvenile dermatomyositis than in the adult form. Inherited myopathies (e.g. Duchenne muscular dystrophy) harbor significant inflammatory infiltrates as well and development of fibrosis was a major feature of skeletal muscle degeneration. A computer-based algorithm was used to quantify fibrosis. The amount of connective tissue increased with the age of patients, while at late stage of disease fatty transformation was an additional important issue.
|
128 |
Role of vascular plasticity in muscle remodeling in the child / Rôle de la plasticité vasculaire dans le remodelage musculaire chez l’enfantGitiaux, Cyril 27 March 2015 (has links)
Le muscle strié squelettique est un tissu richement vascularisé. Au delà de l'apport en oxygène et en nutriments, de nouvelles fonctions des vaisseaux ont été récemment identifiées, par le biais des interactions établies entre les cellules du vaisseau (cellules endothéliales) et les cellules du muscle, en particulier les cellules souches musculaires (cellules satellites). Celles-ci interagissent étroitement avec les cellules endothéliales pour leur expansion et leur différenciation, puis avec les cellules péri-endothéliales pour leur auto-renouvellement et leur retour à la quiescence. Les vaisseaux participent ainsi au contrôle de l’homéostasie du muscle squelettique. Grâce à ces interactions, les cellules vasculaires jouent donc un rôle central dans le remodelage tissulaire après un phénomène destructif, survenant par exemple au cours d’un trauma ou d’une myopathie. Pour étudier, les mécanismes de la plasticité vasculaire au cours du remodelage tissulaire, deux situations paradigmatiques de muscle en régénération chez l’enfant : la dermatomyosite juvénile (DMJ) et la dystrophie musculaire de Duchenne (DMD) ont été étudiées. Il existe, dans ces deux pathologies une souffrance musculaire associée à des cycles de nécrose/régénération. Elles se différencient par leur plasticité vasculaire et par leur évolution. En effet, la DMJ, la myopathie inflammatoire la plus fréquente de l’enfant est caractérisée par une vasculopathie avec perte en capillaires. L’évolution peut être favorable avec restitution ad integrum du muscle. La DMD est une myopathie génétique conduisant à une dégradation progressive de la force musculaire associée à une néovascularisation compensatrice. Le volet clinique/histologique incluant une analyse multiparamétrique des critères évolutifs cliniques et de réponse thérapeutique couplée à une réévaluation des données histologiques de la DMJ (analyse morphométrique des muscles DMJ) a permis de montrer qu’il existait des sous groupes phénotypiques homogènes de sévérité différente dans la DMJ. Le degré de sévérité clinique est relié à la gravité de la vasculopathie musculaire Par ailleurs, des marqueurs cliniques et histologiques simples permettant de repérer au diagnostic les patients nécessitant une escalade thérapeutique rapide (CMAS>34, atteinte gastrointestinale, fibrose endomysiale musculaire au diagnostic) ont été identifiés. Le volet cellulaire a permis l’identification in vitro des interactions cellulaires spécifiques et différentielles des myoblastes issues de patients DMD et DMJ sur les cellules endothéliales normales par l’analyse de leur rôle sur la prolifération, migration et différenciation des cellules vasculaires. Dans la DMD, les myoblastes entrainent une réponse angiogénique importante mais non efficace (néovascularisation anarchique). Dans la DMJ, les myoblastes participent efficacement à la reconstruction vasculaire notamment via la sécrétion de facteurs proangiogéniques. Ces résultats ont été renforcés par analyse transcriptomique effectuée à partir de cellules endothéliales et satellites isolées de muscles de patients confirmant le rôle central de la vasculopathie associée à un contexte inflammatoire spécifique lié à l’interféron dans la physiopathologie de la DMJ et montrant dans la DMD une dérégulation de l’homéostasie normale des interactions vaisseau-muscle avec mise en jeu d’un remodelage tissulaire non efficace. Ces données permettent d'identifier de nouvelles fonctions des cellules vasculaires dans le remodelage du muscle strié squelettique au cours des pathologies musculaires de l'enfant, et devraient ouvrir la voie à de nouvelles approches thérapeutiques. / Skeletal muscle is highly vascularised. Beyond oxygen and nutriment supply, new functions for vessels have been recently identified, through the interactions that vessel cells (endothelial cells) establish with muscle cells, particularly with muscle stem cells (satellite cells). These latter closely interact with endothelial cells for their expansion and their differentiation, then with periendothelial cells for their self-renewal and return to quiescence. During skeletal muscle regeneration endothelial cells reciprocally interact with myogenic cells by direct contact or by releasing soluble factors to promote both myogenesis and angiogenesis processes. Skeletal muscle regeneration typically occurs as a result of a trauma or disease, such as congenital or myopathies. To better understand the role of vessel plasticity in tissue remodeling, we took advantage of two muscular disorders that could be considered as paradigmatic situations of regenerating skeletal muscle in the child: Juvenile Dermatomyositis (JDM), the most frequent inflammatory myopathy and Duchenne Muscular Dystrophy (DMD), the most common type of muscular dystrophy. Although these two muscular disorders share, at the tissue level, similar mechanisms of necrosis-inflammation, they differ regarding the vessel domain. In JDM patients, microvascular changes consist in a destruction of endothelial cells assessed by focal capillary loss. This capillary bed destruction is transient. The tissue remodeling is efficient and muscle may progressively recover its function. By contrast, in DMD, despite an increase of vessels density in an attempt to improve the muscle perfusion, the muscle function progressively alters with age. We identified clinical and pathological markers of severity and predictive factors for poor clinical outcome in JDM by computing a comprehensive initial and follow-up clinical data set with deltoid muscle biopsy alterations controlled by age-based analysis of the deltoid muscle capillarization. We demonstrated that JDM can be divided into two distinctive clinical subgroups. The severe clinical presentation and outcome are linked to vasculopathy. Furthermore, a set of simple predictors (CMAS<34, gastrointestinal involvement, muscle endomysial fibrosis at disease onset) allow early recognition of patients needing rapid therapeutic escalation with more potent drugs. We studied in vitro the specific cell interactions between myogenic cells issued from JDM and DMD patients and normal endothelial cells to explore whether myogenic cells participate to the vessel remodeling observed in the two pathologies. We demonstrated that MPCs possessed angiogenic properties depending on the pathological environment. In DMD, MPCs promoted the development of establishment of an anarchic, although strong, EC stimulation, leading to the formation of weakly functional vessels. In JDM, MPCs enhanced the vessel reconstruction via the secretion of proangiogenic factors. This functional analysis was supported by the transcriptomic analysis consistent with a central vasculopathy in JDM including a strong and specific response to an inflammatory environment. On the contrary, DMD cells presented an unbalanced homeostasis with deregulation of several processes including muscle and vessel development with attempts to recover neuromuscular system by MPCs. To summarize, our data should allow the definition of new functions of vessel cells in skeletal muscle remodelling during muscle pathologies of the child that will open the way to explore new therapeutic options and to gain further insights in the pathogenesis of these diseases.
|
129 |
Estudo morfológico do Sistema Nervoso Central de cães com Distrofia Muscular do Golden Retriever (GRMD) / Morphological study of the Central Nervous System of dogs with Muscular Dystrophy Golden-Retriever (GRMD)Guimarães, Katia de Oliveira Pimenta 04 February 2016 (has links)
Distrofia muscular de Duchenne é uma desordem neuromuscular causada pela mutação ou deleção do gene da distrofina, a qual é ligada ao cromossomo X. Estudos recentes têm demonstrado o importante papel da distrofina no SNC, sendo sua deficiência relacionada com uma variedade de anormalidades na função do SNC, como comportamento e disfunção cognitiva. Os modelos animais mais adequados para esses estudos são os que apresentam o quadro clinico mais semelhante ao da DMD encontrada em humanos, como cães Golden Retriever com distrofia muscular (GRMD). Por não haver ainda estudos a respeito do SNC de animais GRMD, o objetivo deste trabalho foi analisar a morfologia do encéfalo dos GRMD e o de animais não distróficos, através de análise macroscópica, utilizando métodos de medição e registro fotográfico, e análise microscópica, utilizando a técnica de coloração de violeta cresil modificada. Entretanto, usando a metodologia proposta, não foi possível verificar diferenças significativas no encéfalo quando comparados os animais distróficos e os não distróficos, o que está em concordância com a literatura para a DMD usando os mesmos parâmetros. Em tempo, existe uma variação individual na morfologia do encéfalo do cão, independente de serem animais do grupo de distróficos ou controles. Outras técnicas devem ser aplicadas a fim de elucidar as consequências da ausência total ou parcial da distrofina no SNC / Duchenne muscular dystrophy is a neuromuscular disorder caused by the mutation or deletion of the dystrophin gene, which is linked to chromosome X. Recent studies have shown the important role of dystrophin in the CNS, and its related defect with a variety of abnormalities in the function of CNS, such as behavior and cognitive dysfunction. The most suitable animals models for these studies are those with the most similar clinical picture to DMD found in humans, as Golden Retriever dogs with muscular dystrophy (GRMD). There are no further studies on the GRMD animal CNS, and the aim of this study was to analyze the morphology of the brain of GRMD and not dystrophic animals through macroscopic analysis using measurement and photographic registration methods, and microscopic analysis using the modified cresyl violet staining technique. However, using the proposed methodology, we could not find significant differences in the brain when comparing the dystrophic animals and non-dystrophic, which is in agreement with the literature for DMD using the same parameters. In time, there is individual variation in dog brain morphology, whether they are animals of the dystrophic group or controls. Other techniques should be applied in order to elucidate the consequences of the total or partial absence of dystrophin in the CNS
|
130 |
Determinação de elementos de relevância clínica em tecidos biológicos decamundongos distróficos Dmdmdx/J por AAN / Elements determination of clinical relevance in biological tissues of Dmdmdx/j dystrophic mice strains investigated by NAAMetairon, Sabrina 14 March 2012 (has links)
Neste trabalho a determinação de elementos químicos em tecidos biológicos (sangue total, ossos e orgãos) de camundongos distróficos, usados como modelo animal da Distrofia Mucular de Duchenne (DMD), foi realizada utilizando técnica analítica nuclear. O objetivo do presente trabalho foi a determinação dos valores de referência para elementos de relevância em bioquímica clínica (Ca, Cl, K, Mg e Na) e nutricional (Br e S) em sangue total, tíbia, quadríceps anterior e coração de camundongos da linhagem distrófica Dmdmdx/J (10 machos e 10 fêmeas) e grupo controle C57BL/6J (10 machos), utilizando a técnica de Análise por Ativação com Nêutrons AAN. Para obter mais detalhes das alterações que esta disfunção pode causar nesses tecidos biológicos, foram calculadas matrizes de correlação entre as espécies Dmdmdx/J e comparadas ao grupo controle C57BL/6J. Para a realização deste estudo 119 amostras de tecidos biológicos foram irradiadas no reator nuclear IEA-R1 no IPEN (São Paulo, Brasil). Os resultados de análise, por AAN, constituem as primeiras estimativas para os valores de referência nesses tecidos biológicos dos camundongos Dmdmdx/J e C57BL/6J. Além disso, as alterações em alguns dos coeficientes de correlações entre os animais saudáveis e com disfunção indicam uma conexão entre esses elementos no sangue, tíbia, quadríceps e coração. Esses dados poderão auxiliar pesquisadores avaliar e comparar as vantagens e desvantagens dos diferentes tratamentos, realizados na distrofia muscular, quando estes modelos animais forem empregados, auxiliando os pesquisadores a avaliar a eficácia de novos procedimentos terapêuticos antes de serem empregados em paciente com DMD. / In this work the determination of chemistry elements in biological tissues (whole blood, bones and organs) of dystrophic mice, used as animal model of Duchenne Muscular Dystrophy (DMD), was performed using analytical nuclear technique. The aim of this work was to determine reference values of elements of clinical (Ca, Cl, K, Mg, Na) and nutritional (Br and S) relevance in whole blood, tibia, quadriceps and hearts from Dmdmdx/J (10 males and 10 females) dystrophic mice and C57BL/6J (10 males) control group mice, using Neutron Activation Analysis technique (NAA). To show in more details the alterations that this disease may cause in these biological tissues, correlations matrixes of the DMDmdx/J mouse strain were generated and compared with C57BL/6J control group. For this study 119 samples of biological tissue were irradiated in the IEA-R1 nuclear reactor at IPEN (São Paulo, Brazil). The concentrations of these elements in biological tissues of Dmdmdx/J and C57B/6J mice are the first indicative interval for reference values. Moreover, the alteration in some correlation coefficients data among the elements in the health status and in the diseased status indicates a connection between these elements in whole blood, tibia, quadriceps and heart. These results may help the researchers to evaluate the efficiency of new treatments and to compare the advantages of different treatment approaches before performing tests in patients with muscular dystrophy.
|
Page generated in 0.0871 seconds